SARS-CoV-2 Inhibitors Based on Disruption of the Ribosomal Frameshifting Element

  • Garcia-Blanco, Mariano (PI)

Project: Other project

Project Details

StatusFinished
Effective start/end date7/1/2112/31/22

Funding

  • Arrakis Therapeutics: $140,552.80